Skip to Main Content

Paper Details

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Cancers (Basel)
6
2020

Datasets

Release 1.2